# Promoting Alternatives to Sulfonylureas to Improve Patient Safety in Type 2 Diabetes

> **NCT05933174** · NA · RECRUITING · sponsor: **Ian J. Neeland, MD** · enrollment: 220 (estimated)

## Conditions studied

- Type2diabetes

## Interventions

- **OTHER:** Prompt-sheet
- **OTHER:** Usual education

## Key facts

- **NCT ID:** NCT05933174
- **Lead sponsor:** Ian J. Neeland, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2025-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05933174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05933174, "Promoting Alternatives to Sulfonylureas to Improve Patient Safety in Type 2 Diabetes". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05933174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*